Summary

Hospital and community laboratories are requested to refer all Shigella isolates from cases of shigellosis to ESR for serotyping and biotyping as part of the laboratory-based surveillance of this disease. The antimicrobial susceptibility of viable, non-duplicate Shigella isolates referred to ESR in 2015 and 2016 was tested. This is the first antimicrobial susceptibility survey of Shigella that ESR had undertaken since 1996.